Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Follicular Lymphoma
- Non Hodgkin Lymphoma
- Relapsed Follicular Lymphoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Intervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03806179
- Collaborators
- ICON Clinical Research
- Investigators
- Principal Investigator: Arne Kolstad, MD.PhD Oslo University Hospital
Get Well Soon